Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females

Behavioural Brain Research

Volumn 262, Issue , 2014, Pages 84-93

  Robles, Cindee F ^a,b   McMackin, Marissa Z ^a   Campi, Katharine L ^a,c   Doig, Ian E ^a   Takahashi, Elizabeth Y ^a   Pride, Michael C ^a   Trainor, Brian C ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aversion; Kappa opioid receptor; Sex Difference; Social behavior

Indexed keywords

AVERSION; KAPPA OPIOID RECEPTOR; SEX DIFFERENCE; SOCIAL BEHAVIOR;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; AVOIDANCE LEARNING; CONDITIONING (PSYCHOLOGY); FEMALE; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; NUCLEUS ACCUMBENS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, OPIOID, KAPPA; SEX FACTORS; SOCIAL BEHAVIOR;

EID: 84893409233     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.01.003     Document Type: Article

References (86)

1. Bals-Kubik R., Albeitner A., Herz A., Shippenberg T.S. Neuroanatomical sties mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 1993, 264:489-495.
2. Bals-Kubik R., Herz A., Shippenberg T.S. Evidence that the aversive effects of opioid antagonists and κ-agonists are centrally mediated. Psychopharmacology 1989, 98:203-206.
3. Bechara A., Van Der Kooy D. Kappa receptors mediate the peripheral aversive effects of opiates. Pharm Biochem Behav 1987, 28:227-233.
4. Belcheva M.M., Clark A.L., Haas P.D., Serna J.S., Hahn J.W., Kiss A., Coscia C.J. mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. J Biol Chem 2005, 280:27662-27669.
5. Bester-Meredith J.K., Marler C.A. The association between male offspring aggression and paternal and maternal behavior of Peromyscus mice. Ethology 2003, 109:797-808.
6. Bhargava H.N., Gulati A., Ramarao P. Effect of chronic administration of U50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. J Pharmacol Exp Ther 1989, 251:21-26.
7. Bilkei-Gorzo A., Racz I., Michel K., Mauer D., Zimmer A., Klingmuller D., et al. Control of hormonal stress reactivity by the endogenous opioid system. Psychoneuroendocrinology 2008, 33:425-436.
8. Bolanos C.A., Garmsen G.M., Clair M.A., McDougall S.A. Effects of the k-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developming rat. Eur J Pharmacol 1996, 317:1-8.
9. Brent P.J., Bot G. Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs. Psychopharmacology (Berl) 1992, 107:581-590.
10. Bruchas M., Chavkin C. Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology 2010, 210:137-147.
11. Bruchas M.R., Land B.B., Aita M., Xu M., Barot S.K., Li S., et al. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J Neurosci 2007, 27:11614-11623.
12. Bruchas M.R., Macey T.A., Lowe J.D., Chavkin C. Kappa opioid receptor activation of p38 MAPK is GRK3-and arrestin-dependent in neurons and astrocytes. J Biol Chem 2006, 281:18081-18089.
13. Bruchas M.R., Schindler A.G., Shankar H., Messinger D.I., Miyatake M., Land B.B., et al. Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron 2011, 71:498-511.
14. Bruchas M.R., Xu M., Chavkin C. Repeated swim stress induced kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2. Neuroreport 2008, 19:1417-1422.
15. Campi K.L., Greenberg G.D., Kapoor A., Ziegler T.E., Trainor B.C. Sex differences in effects of dopamine D1 receptors on social withdrawal. Neuropharmacology 2014, 77:208-216.
16. Campi K.L., Jameson C., Trainor B.C. Sexual dimorphism in the brain of the monogamous California mouse (Peromyscus californicus). Brain Behav Evol 2013, 81:236-249.
17. Chartoff E.H., Potter D., Damez-Werno D., Cohen B.M., Carlezon W.A. Exposure to the selective k-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of coaine in rats. Neuropsychopharmacology 2008, 33:2676-2687.
18. Chaudhury D., Walsh J.J., Friedman A.K., Juarez B., Ku S.M., Koo J.W., et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 2013, 493:532-536.
19. Chavkin C., James I.F., Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 1982, 215:413-415.
20. Chefer VI, Backman CM, Gigante ED, Shippenberg TS. Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology; 2013.
21. Clark J.A., Pasternak G.W. U50,488: a kappa-selective agent with poor affinity for mu1 opiate binding sites. Neuropharmacology 1988, 27:331-332.
22. Del Pozo E., Barrios M., Baeyens J.M. The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice. Psychopharmacology 1996, 125:209-213.
23. Feng X., Wu C.-Y., Burton F.H., Loh H.H., Wei L.-N. β-arrestin protects neurons by mediating endogenous opioid arrest of inflammatory microglia. Cell Death Differ 2013, [in press]. 10.1038/cdd.2013.152.
24. Fenn A.M., Gensel J.C., Huang Y., Popovich P.G., Lifshitz J., Godbout J.P. Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia. Biol Psychiatry 2013, [in press]. 10.1016/j.biopsych.2013.10.014.
25. Frank M.G., Baratta M.V., Sprunger D.B., Watkins L.R., Maier S.F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 2007, 21:47-59.
26. Fuxjager M.J., Mast G., Becker E.A., Marler C.A. The 'home advantage' is necessary for a full winner effect and changes in post-encounter testosterone. Hormones Behav 2009, 56:214-219.
27. Gear R.W., Gordon N.C., Heller P.H., Paul S., Miaskowski C., Levine J.D. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett 1996, 205:207-209.
28. Gear R.W., Miaskowski C., Gordon N.C., Paul S.M., Heller P.H., Levine J.D. Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med 1996, 2:1248-1250.
29. Graeber M.B. Changing face of microglia. Science 2010, 330:783-788.
30. Greenberg G.D., Laman-Maharg A., Campi K.L., Voigt H., Orr V.N., Simion C., et al. Sex differences in stress-induced social withdrawal: role of brain derived neurotrophic factor in the bed nucleus of the stria terminalis. Front Behav Neurosci 2014, 7:223.
31. Hara Y., Yakovleva T., Bakalkin G., Pickel V.M. Dopamine D1 receptors have subcellular distributions conducive to interactions with prodynorphin in the rat nucleus accumbens shell. Synapse 2006, 60:1-19.
32. Harris B.N., Saltzman W., De Jong T.R., Milnes M.R. Hypothalamic-pituitary-adrenal (HPA) axis function in the California mouse (Peromyscus californicus): changes in baseline activity, reactivity, and fecal excretion of glucocorticoids aross the diurnal cycle. Gen Comp Endocrinol 2012, 179:436-450.
33. Kavaliers M., Innes D. Stress-induced opiod analgesia and activity in deer mice: sex and population differences. Brain Res 1987, 425:49-56.
34. Kavaliers M., Choleris E. Sex differences in N-methyl-D-aspartate involvement in kappa opioid and non-opioid predator-induced analgesia in mice. Brain Res 1997, 768:30-36.
35. Kavaliers M., Colwell D.D., Choleris E. Sex differences in opioid and N-methyl-D-aspartate mediated non-opioid biting fly exposure induced analgesia in deer mice. Pain 1998, 77:163-171.
36. Kavaliers M., Innes D.G.L. Sex and day-night differences in opiate-induced responses of insular wild deer mice Peromyscus maniculatus triangularis. Pharmacol Biochem Behav 1987, 27:477-482.
37. Klein S.L., Nelson R.J. Sex differences in immunocompetence differ between two Peromyscus species. Am J Physiol 1997, 273:R655-R660.
38. Knoll A.T., Carlezon W.A. Dynorphin, stress, and depression. Brain Res 2010, 1314:56-73.
39. Knoll A.T., Meloni E.G., Thomas J.B., Carroll F.I., Carlezon W.A. Anxiolytic-like effects of κ-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 2007, 323:838-845.
40. Kudryavtseva N.N., Bondar N.P., Alekseyenko O.V. Behavioral correlates of learned aggression in male mice. Agg Behav 2000, 26:386-400.
41. Kudryavtseva N.N., Gerrits M.A.F.M., Avgustinovich D.F., Tenditnik M.V., Van Ree J.M. Anxiety and ethanol consumption in victorious and defeated mice; effect of κ-opioid receptor activation. Eur Neuropsychopharmacol 2006, 16:504-511.
42. Land B.B., Bruchas M.R., Lemos J.C., Xu M., Melief E.J., Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J. Neurosci. 2008, 28:407-414.
43. Lemos J.C., Roth C.A., Messinger D.I., Gill H.K., Phillips P.E.M., Chavkin C. Repeated stress dysregulates k-opioid receptor signaling in the dorsal raphe through a p38a MAPK-dependent mechanism. J Neurosci 2012, 32:12325-12336.
44. Leyton M., Stewart J. The stimulation of central k opioid receptors decreases male sexual behavior and locomotor activity. Brain Res 1992, 594:56-74.
45. Li C., Pleil K.E., Stamatakis A.M., Busan S., Vong L., Lowell B.B., et al. Presynaptic inhibition of gamma-aminobutytic acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling. Biol Psychiatry 2012, 71:725-732.
46. Liu N.-J., Schnell S., Wessendorf M.W., Gintzler A.R. Sex, pain, and opioids: interdependent influences of sex and pain modality on dynorphin-mediated antinociception in rats. J Pharmacol Exp Ther 2013, 344:522-530.
47. Markham C.M., Taylor S.L., Huhman K.L. Role of amygdala and hippocampus in the neural circuit subserving conditioned defeat in Syrian hamsters. Learn Mem 2010, 17:109-116.
48. McLaughlin J.P., Li S., Valdez J., Chavkin T.A., Chavkin C. Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 2006, 31:1241-1248.
49. McLaughlin J.P., Marton-Popovici M., Chavkin C. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 2003, 23:5674-5683.
50. McLaughlin J.P., Myers L.C., Zarek P.E., Caron M.G., Lefkowitz R.J., Czyzyk T.A., et al. Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J Biol Chem 2004, 279:1810-1818.
51. Miczek K.A., Nikulina E.M., Shimamoto A., Covington H.E. Escalated or suppressed cocaine reward, tegmental BDNF, and accumbal dopamine caused by episodic versus continuous social stress in rats. J Neurosci 2011, 31:9848-9857.
52. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
53. Mineur Y.S., Prasol D.J., Belzung C., Crusio W.E. Agonistic behavior and unpredictable chronic mild stress in mice. Behav Genet 2003, 33:513-519.
54. Mogil J.S., Wilson S.G., Chesler E.J., Rankin A.L., Nemmani K.V., Lariviere W.R., et al. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci U S A 2003, 100:4867-4872.
55. Mucha R.F., Herz A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste conditioning. Psychopharmacology 1985, 86:274-280.
56. Nair A., Bonneau R.H. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol 2006, 171:72-85.
57. O'Connell L.A., Hofmann H.A. The vertebrate mesolimbic reward system and social behavior network: a comparative synthesis. J Comp Neurol 2011, 3599-3639.
58. O'Connell L.A., Hofmann H.A. Evolution of a vertebrate social decision-making network. Science 2012, 336:1154-1157.
59. Pfaus J.G., Pfaff D.W. μ-, δ- and κ-opioid receptor agonists selectively modulate sexual behaviors in the female rat: differential dependence on progesterone. Horm Behav 1992, 26:457-473.
60. Pfeiffer A., Brantl V., Herz A., Emrich H.M. Psychotomimesis mediated by κ opiate receptors. Science 1986, 233:774-776.
61. Potter D.N., Damez-Werno D., Carlezon W.A., Cohen B.M., Chartoff E.H. Repeated exposure to the k-opioid receptor agonist salvinorin a modulates extracellular signal-regulated kinase and reward sensitivity. Biol Psychiatry 2011, 70:744-753.
62. Privette T.H., Terrian D.M. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze. Psychopharmacology 1995, 118:444-450.
63. Prus AJ, James JR, Rosencrans JA. Conditioned place preference. In: Buccafusco JJ, editor. Methods of behavior analysis in neuroscience. Boca Raton, FL: CRC Press; 2009.
64. Rasakham K., Liu-Chen L.-Y. Sex differences in kappa opioid pharmacology. Life Sci 2011, 88:2-16.
65. Resendez S.L., Kuhnmuench M., Krzywosinski T., Aragona B.J. κ-opioid receptor within the nucleus accumbens shell mediate pair bond maintenance. J Neurosci 2012, 32:6771-6784.
66. Russell S.E., Rachlin A.B., Smith K.L., Muschamp J.W., Berry L., Zhao Z., et al. Sex difference in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats. Biol Psychiatry 2013, [in press]. 10.1016/j.biopsych.2013.07.042.
67. Schindler A.G., Messinger D.I., Smith J.S., Shankar H., Gustin R.M., Schattauer S.S., et al. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. J Neurosci 2012, 32:17582-17596.
68. Schmid C.L., Streicher J.M., Groer C.E., Munro T.A., Zhou L., Bohn L.M. Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons. J Biol Chem 2013, 288:22387-22398.
69. Silva A.L., Fry W.H., Sweeney C., Trainor B.C. Effects of photoperiod and experience on aggressive behavior in female California mice. Behav Brain Res 2010, 208:528-534.
70. Sora I., Elmer G., Funada M., Pieper J., Li X.-F., Hall F.S., et al. μ opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo μ receptor reserve. Neuropsychopharmacology 2001, 25:41-54.
71. Tanaka K., Furuyashiki T., Kitaoka S., Senzai Y., Imoto Y., Segi-Nishida E., et al. Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice. J Neurosci 2012, 32:4319-4329.
72. Trainor B.C., Crean K.K., Fry W.H.D., Sweeney C. Activation of extracellular signal-regulated kinases in social behavior circuits during resident-intruder aggression tests. Neuroscience 2010, 165:325-336.
73. Trainor B.C., Greiwe K.M., Nelson R.J. Individual differences in estrogen receptor α in select brain nuclei are associated with individual differences in aggression. Horm Behav 2006, 50:338-345.
74. Trainor B.C., Pride M.C., Villalon Landeros R., Knoblauch N.W., Takahashi E.Y., Silva A.L., et al. Sex differences in social interaction behavior following social defeat stress in the monogamous California mouse (Peromyscus californicus). PLOS One 2011, 6:e17405.
75. Trainor B.C., Takahashi E.Y., Campi K.L., Florez S.A., Greenberg G.D., Laman-Maharg A., et al. Sex differences in stress-induced social withdrawal: independence from adult gonadal hormones and inhibition of female phenotype by corncob bedding. Horm Behav 2013, 63:543-550.
76. Tynan R.J., Naicker S., Hinwood M., Nalivaiko E., Buller K.M., Pow D.V., et al. Chronic stress alterrs the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun 2010, 24:1058-1068.
77. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehenzive review of drug effects, recent progress and new issues. Prog Neurobiol 1998, 56:613-672.
78. Tzschentke T.M., Schmidt W.J. N-Methyl-D-aspartic acid receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 1995, 193:37-40.
79. Wake H., Moorhouse A.J., Jinno S., Kohsaka S., Nabekura J. Resting microglia directly monitor the functional state of synapses In vivo and determine the fate of ischemic terminals. J Neurosci 2009, 29:3974-3980.
80. Walsh S.L., Geter-Douglas B., Strain E.C., Bigelow G.E. Endoline and butorphanol: evaluation of k-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther 2001, 299:147-158.
81. Wang Y.J., Rasakham K., Huang P., Chudnovskaya D., Cowan A., Liu-Chen L.Y. Sex difference in kappa-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[S-35]thiotriphosphate) binding in the guinea pig. J Pharmacol Exp Ther 2011, 339:438-450.
82. Wiley M.D., Poveromo L.B., Antapasis J., Herrera C.M., Bolaños Guzmán C.A. k-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate. Neuropsychopharmacology 2009, 34:1339-1350.
83. Williams S.A., Jasarevic E., Vandas G.M., Warzak D.A., Geary D.C., Ellersieck M.R., et al. Effects of developmental bisphenol A exposure on reproductive-related behaviors in california mice (Peromyscus californicus): a monogamous animal model. PloS One 2013, 8:e55698.
84. Wittmann W., Schunk E., Rosskothen I., Gaburro S., Singewald N., Herzog H., et al. Prodyndophin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology 2009, 34:775-785.
85. Zhou L., Lovell K.M., Frankowski K.J., Slauson S.R., Phillips A.G., Streicher J.M., et al. Development of functionally selective small molecule agonists at kappa opioid receptors. J Biol Chem 2013, 288:36703-36716.
86. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001, 15:199-226.